Jiali Tang v. Synutra International, Inc.

656 F.3d 242, 2011 U.S. App. LEXIS 18490
CourtCourt of Appeals for the Fourth Circuit
DecidedSeptember 6, 2011
DocketNo. 10-1487
StatusPublished
Cited by2 cases

This text of 656 F.3d 242 (Jiali Tang v. Synutra International, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jiali Tang v. Synutra International, Inc., 656 F.3d 242, 2011 U.S. App. LEXIS 18490 (4th Cir. 2011).

Opinion

Affirmed by published opinion. Judge WYNN wrote the opinion, in which Judge KING and Judge GREGORY concurred.

OPINION

WYNN, Circuit Judge:

“A forum non conveniens dismissal must be based on the finding that, when weighed against plaintiffs choice of forum, the relevant public and private interests strongly favor a specific, adequate, and available alternative forum.”1 Plaintiffs in this case are citizens and residents of China who allege that they were injured by melamine-contaminated infant formula in China. The contaminated products were manufactured and distributed exclusively in China by, among others, Sheng Yuan Nutritional Food Company (“Sheng Yuan”) — a Chinese subsidiary of Synutra International, Incorporated and Synutra, Incorporated (collectively “Synutra”). Because Synutra’s principal place of business is in Maryland, Plaintiffs brought this action in Maryland seeking to recover damages for their alleged injuries that occurred in China. China, however, is an available, adequate, and more convenient forum to redress Plaintiffs’ grievances; accordingly, we affirm the district court’s forum non conveniens dismissal.

I.

In 2008, Chinese officials learned of widespread reports that infants in China had died or become severely ill after consuming infant formula. An investigation showed that infant formula manufactured by twenty-two Chinese companies was contaminated with melamine, a chemical which is unfit for human consumption and may afflict the kidneys.2 One of these companies was Sheng Yuan, a subsidiary of Synutra. According to Synutra’s 2009 financial statement to the United States Securities and Exchange Commission, Sheng Yuan produced, marketed and sold infant formula products in China,

[djirectly or through its wholly owned subsidiary, Synutra, Ine[orporated], an Illinois corporation (“Synutra Illinois”), Synutra International, Inc. (collectively with its subsidiaries, “the Company” or “Synutra”) owns all or majority of the equity interests of the companies in the People’s Republic of China (“China” or “PRC”) that are principally engaged in the production, marketing and distribution of dairy based nutritional products under the Company’s own brands in [247]*247China. The Company is a leader in sales of infant formula products in China.
The Company produces, markets and sells nutritional products under “Sheng Yuan,” or “Synutra,” its master brand, and several sub-brands, including “Super,” “U-Smart,” and “U-Strong.”

On September 16, 2008, Synutra issued a press release in China recalling the “U-Smart” line of formula products. In the press release, Synutra acknowledged that batches of its U-Smart products were found to be contaminated, and the company expressed regret for harm caused to Chinese children. Synutra believed “that the melamine contamination resulted from tainted milk supplies provided by third-party suppliers in the Hebei and Inner Mongolia regions of China.”

In December 2008, the Chinese government established a fund to compensate the children and families affected by contaminated infant formula (“the Fund”). The Chinese government executed contracts with the twenty-two responsible infant formula manufacturers, which agreed to contribute to the Fund. The Chinese government agreed to administer the Fund by making distributions, through China Life Insurance Company Limited, to affected children and their families.

In March 2009, a government official estimated that “over 95% of 300,000 infants with different levels of suffering from baby formula ha[d] accepted compensation” from the Fund, thus waiving then-rights to sue. But some of the victims elected to bring civil lawsuits in China’s courts in lieu of accepting compensation from the Fund. The record shows that some of those lawsuits were accepted3 by provincial or municipal-level Chinese courts. On March 2, 2009, Shen Deyong, Executive Vice President of the Supreme People’s Court, the highest court in the People’s Republic of China, officially announced that the court “is prepared and ready to hear these cases according to law at any time.”

On the other hand, the record also shows evidence that some of the contaminated infant formula lawsuits were stymied by China’s courts and government officials. For instance, in 2008, the United States’ Congressional-Executive Commission on China4 released a report stating:

Chinese authorities are preventing citizens with grievances related to tainted milk products from using the judicial system to seek redress. They have invoked the importance of “maintaining social stability” in seeking to thwart efforts to organize large groups of angry citizens through collective lawsuits.
By early October, more than 100 lawyers nationwide had joined forces to offer free legal aid to the parents of babies who had fallen sick from tainted milk. Many of the lawyers have been pressured to withdraw from the group.... Judicial authorities in some provinces have told volunteer lawyers that litigation could lead to “social unrest.”

Staff of Cong.-Exec. Comm’n on China, 110th Cong., Annual Report 164 (2008). Additionally, consistent with the Commission’s findings, affidavits from at least two [248]*248Chinese lawyers stated that Chinese courts continued to delay contaminated infant formula cases even after the Supreme People’s Court’s March 2, 2009 announcement. These lawyers acknowledged, however, that at least two cases were eventually accepted.5 One of the lawyers also asserted that he was pressured by government officials to withdraw from contaminated infant formula litigation.

On January 15, 2009, in lieu of accepting compensation under the Fund, Plaintiffs in this matter chose to institute this action against Synutra in the United States District Court in Maryland, rather than in China. They alleged various causes of action based on Synutra’s role in producing, marketing, and distributing contaminated U-Smart products. Synutra moved to dismiss the complaint on the basis of, inter alia, forum non conveniens, contending that China is a more convenient forum for Plaintiffs’ claims. Plaintiffs opposed Synutra’s motion, and both parties submitted affidavits from Chinese lawyers and law professors familiar with the contaminated infant formula incident and related lawsuits.

The district court, in ruling on the motion, found China to be an available forum based on the affidavit of Synutra’s President, Weiguo Zhang, who affirmed that Synutra would not contest service of process if Plaintiffs filed this lawsuit in China. Tang v. Synutra Int'l, Inc., No. DKC 09-0088, 2010 WL 1375373, *5 (D.Md. Mar. 29, 2010). Next, the district court found that China is an adequate forum, despite conflicting evidence regarding the willingness of China’s courts to hear and resolve contaminated formula cases. The district court also deemed China adequate because “[e]ven if the Chinese courts were not open to Plaintiffs, another remedy is undisputedly available to them, namely, the [Fund].” Id. at *10. Finally, the district court weighed the public and private interests and concluded that they “overwhelmingly” favored China as the more appropriate forum for this dispute. Id. at *12.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

in Re Shelby Longoria
Court of Appeals of Texas, 2015
Jiali Tang v. SYNUTRA INTERN., INC.
656 F.3d 242 (Fourth Circuit, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
656 F.3d 242, 2011 U.S. App. LEXIS 18490, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jiali-tang-v-synutra-international-inc-ca4-2011.